Indegene Wins Deloitte Technology Fast 50 India 2024 Award in HealthTech

Indegene, a digital-first life sciences commercialization company, announced that it is a winner in HealthTech at the Deloitte Technology Fast 50 India 2024 Awards, for the second consecutive year. Now in its 19th edition, the Deloitte Technology Fast 50 India programme celebrates and honours the fastest-growing technology-enabled businesses based on their average revenue growth over a three-year period.

Thriving in a competitive and ever-evolving environment while addressing global uncertainties and disruptions demands relentless innovation, adaptability, and an exceptional ability to harness technology effectively. Deloitte firmly believes that the Top 50 winners of its 2024 list exemplify these qualities, and the winners' accomplishments highlight their resilience and ingenuity, setting new benchmarks for the industry.

Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products. It is one of the very few companies globally where a medical doctor and a data scientist work next to each other to solve big, impactful problems in life sciences. And this is by design. More than 20% of Indegene's employees come from a medical education background and they work very closely with about 600 technologists who work on advanced artificial intelligence (AI), machine learning (ML) and other technologies.

Take generative AI (GenAI) for example. Indegene remains focused on helping its clients harness the potential of GenAI with targeted solutions to address some of their most pressing operational challenges and make their business futureready. In summary, Indegene's investments in real-world data and digital tools continue to help its clients navigate changing regulatory environments and improve operational efficiency around the world.

With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene's client base includes the world's top 20 biopharma companies, many emerging biotech firms, and medical device companies. With over 5,000 employees worldwide, Indegene's vast global footprint underscores its ability to scale and meet the evolving needs of the world's leading pharma organizations across markets.

Shares of Indegene Limited was last trading in BSE at Rs. 628.40 as compared to the previous close of Rs. 636.95. The total number of shares traded during the day was 28882 in over 1253 trades.

The stock hit an intraday high of Rs. 637.05 and intraday low of 623.20. The net turnover during the day was Rs. 18166432.00.

Source : Equity Bulls

Keywords

Indegene HealthcareResearch Analytics Technology INE065X01017 Award DeloitteTechnologyFast50India2024